Search research articles
Contact Us
Filters
Showing results (911-920 of 937) with videos related to
Page
of 94
Sort By:
Scientific Reports
|
February 22, 2022
Sex-specific disease modifiers in juvenile myoclonic epilepsy
Amy Shakeshaft, Naim Panjwani, Amber Collingwood, et al.
Elife
|
March 16, 2022
Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease
Vivian Vasconcelos Costa, Michelle A Sugimoto, Josy Hubner, et al.
British Journal of Haematology
|
December 19, 2014
Use of eltrombopag after romiplostim in primary immune thrombocytopenia
José Ramón González-Porras, María Eva Mingot-Castellano, Marcio M Andrade, et al.
European Journal of Endocrinology
|
April 7, 2025
Deleterious variants in intolerant genes reveal new candidates for self-limited delayed puberty
Raíssa C Rezende, Wen He, Lena R Kaisinger, et al.
European Journal of Haematology
|
December 29, 2015
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice
Tomás José González-López, María Teresa Alvarez-Román, Cristina Pascual, et al.
Cell Reports
|
January 29, 2022
Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection
Kylie M Konrath, Kevin Liaw, Yuanhan Wu, et al.
Nature
|
December 10, 2019
Importance and vulnerability of the world's water towers
W W Immerzeel, A F Lutz, M Andrade, et al.
American Journal of Human Genetics
|
September 26, 2017
De Novo Mutations in PPP3CA Cause Severe Neurodevelopmental Disease with Seizures
Candace T Myers, Nicholas Stong, Emily I Mountier, et al.
Epilepsia
|
July 7, 2017
Epilepsy: Transition from pediatric to adult care. Recommendations of the Ontario epilepsy implementation task force
Danielle M Andrade, Anne S Bassett, Eduard Bercovici, et al.
Nature Communications
|
October 6, 2022
DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2
Elizabeth M Parzych, Jianqiu Du, Ali R Ali, et al.
Page
of 94
Search research articles
Search
Showing results (911-920 of 937) with videos related to
Sort By:
Page
of 94
Scientific Reports
|
February 22, 2022
Sex-specific disease modifiers in juvenile myoclonic epilepsy
Amy Shakeshaft, Naim Panjwani, Amber Collingwood, et al.
Elife
|
March 16, 2022
Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease
Vivian Vasconcelos Costa, Michelle A Sugimoto, Josy Hubner, et al.
British Journal of Haematology
|
December 19, 2014
Use of eltrombopag after romiplostim in primary immune thrombocytopenia
José Ramón González-Porras, María Eva Mingot-Castellano, Marcio M Andrade, et al.
European Journal of Endocrinology
|
April 7, 2025
Deleterious variants in intolerant genes reveal new candidates for self-limited delayed puberty
Raíssa C Rezende, Wen He, Lena R Kaisinger, et al.
European Journal of Haematology
|
December 29, 2015
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice
Tomás José González-López, María Teresa Alvarez-Román, Cristina Pascual, et al.
Cell Reports
|
January 29, 2022
Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection
Kylie M Konrath, Kevin Liaw, Yuanhan Wu, et al.
Nature
|
December 10, 2019
Importance and vulnerability of the world's water towers
W W Immerzeel, A F Lutz, M Andrade, et al.
American Journal of Human Genetics
|
September 26, 2017
De Novo Mutations in PPP3CA Cause Severe Neurodevelopmental Disease with Seizures
Candace T Myers, Nicholas Stong, Emily I Mountier, et al.
Epilepsia
|
July 7, 2017
Epilepsy: Transition from pediatric to adult care. Recommendations of the Ontario epilepsy implementation task force
Danielle M Andrade, Anne S Bassett, Eduard Bercovici, et al.
Nature Communications
|
October 6, 2022
DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2
Elizabeth M Parzych, Jianqiu Du, Ali R Ali, et al.
Page
of 94